G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $431,280 | -46.0% | 299,500 | -6.6% | 0.00% | – |
Q2 2023 | $798,720 | -19.1% | 320,771 | -12.9% | 0.00% | – |
Q1 2023 | $986,972 | -59.4% | 368,273 | -17.8% | 0.00% | -100.0% |
Q4 2022 | $2,433,140 | -25.2% | 448,092 | +72.2% | 0.00% | 0.0% |
Q3 2022 | $3,251,000 | +535.0% | 260,262 | +150.9% | 0.00% | – |
Q2 2022 | $512,000 | -55.7% | 103,728 | -31.9% | 0.00% | – |
Q1 2022 | $1,157,000 | -76.1% | 152,295 | -67.9% | 0.00% | – |
Q4 2021 | $4,846,000 | +56.4% | 474,672 | +105.6% | 0.00% | – |
Q3 2021 | $3,098,000 | -46.4% | 230,846 | -12.4% | 0.00% | – |
Q2 2021 | $5,779,000 | -63.7% | 263,393 | -60.2% | 0.00% | -100.0% |
Q1 2021 | $15,934,000 | +1.4% | 662,244 | -24.2% | 0.00% | +50.0% |
Q4 2020 | $15,716,000 | +1528.6% | 873,628 | +946.7% | 0.00% | – |
Q3 2020 | $965,000 | +7.2% | 83,468 | +124.9% | 0.00% | – |
Q2 2020 | $900,000 | +212.5% | 37,110 | +42.1% | 0.00% | – |
Q1 2020 | $288,000 | -65.2% | 26,120 | -16.6% | 0.00% | – |
Q4 2019 | $828,000 | -53.6% | 31,337 | -60.0% | 0.00% | – |
Q3 2019 | $1,784,000 | -58.9% | 78,298 | -44.8% | 0.00% | – |
Q2 2019 | $4,343,000 | +1103.0% | 141,740 | +553.2% | 0.00% | – |
Q1 2019 | $361,000 | -46.5% | 21,700 | +68.2% | 0.00% | – |
Q3 2018 | $675,000 | – | 12,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |